Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other neoplasm 3

Conditions

Breast Neoplasms 1780Neoplasms 1500Carcinoma, Non-Small-Cell Lung 1045Prostatic Neoplasms 958Colorectal Neoplasms 882Lung Neoplasms 803Pancreatic Neoplasms 573Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 541Stomach Neoplasms 513Ovarian Neoplasms 508Neoplasm Metastasis 499Multiple Myeloma 494Recurrence 412Melanoma 387Squamous Cell Carcinoma of Head and Neck 370Brain Neoplasms 362Uterine Cervical Neoplasms 361Head and Neck Neoplasms 356Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 306Endometrial Neoplasms 305Triple Negative Breast Neoplasms 299Glioblastoma 299Rectal Neoplasms 282Sarcoma 266Urinary Bladder Neoplasms 264Hematologic Neoplasms 264Colonic Neoplasms 255

Interventions

trametinib 1dabrafenib 1Surgical Procedures, Operative 1Pharmaceutical Preparations 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Rare Malignant Neoplasm × Clear all
NCT06119789 2025-03-26

MATRIX-Rare

Oslo University Hospital

Phase 2 Recruiting
96 enrolled
Other neoplasm

Rare Malignant Neoplasm

NCT06872853 2025-03-12

RAC

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting
1,100 enrolled
Other neoplasm

Rare Malignant Neoplasm

NCT05217407 2024-03-22

MASTERKEY ASIA

National Cancer Center, Japan

Recruiting
1,000 enrolled
Other neoplasm

Rare Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡